Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

The Future of Wearables? Consolidation.

Investors say the space will get more interesting with coming smartwatches and sensors.

Shutterstock / JMicic

At the Bloomberg Next Big Thing Summit on Monday, investor Esther Dyson predicted a coming wave of consolidation for the nascent wearables sector.

“It’s extremely crowded now,” said Dyson, chair of EDventure Holdings, during the opening session of the conference at the Cavallo Point Lodge in Sausalito, Calif., which offered attendees a postcard view of the Golden Gate Bridge.

It’s not that she isn’t a fan of the space. Her wrist basically echoed her point, as she came onstage wearing a Nike FuelBand, the Misfit Shine and the Basis. Dyson has also invested in the space personally, putting money into GOQii.

But the wearables market has already become commoditized, cluttered with devices that offer very few points of differentiation (check out the long list here). Most count steps, estimate calories and maybe monitor sleep. Many people, however, simply stop using them within a few weeks or months. The data doesn’t end up helping them make meaningful lifestyle changes.

Bloomberg’s Emily Chang, who moderated the session, made this point. She has tried a series of them, but the habit never took.

It’s also a low-margin business, which is one reason Nike is already stepping out of the hardware side.

Dyson said wearables will get much more interesting as the devices include more sensors, notably one that can monitor glucose levels without pricking the skin. That could provide continual feedback, showing people exactly how the things they ingest affect their health. (Various researchers are at work on this problem, including at Google X, but we’re likely years away from such a medical device earning regulatory approval.)

During the same session, angel investor Ron Conway said that various smartwatches rumored to be nearing the market could point to an inflection point for the space. He said they’ll go from offering basic health metrics — which seems to appeal to a barbell niche of the very healthy and very unhealthy — to offering smartphone-like functionality, including the ability to check emails and make calls.

“I think that’s when you’ll see them become even more mainstream,” he said.

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh